Douglas Evan Godshall Shockwave Medical, Inc. (SWAV) insider trading activity

Douglas Evan Godshall is President & CEO of Shockwave Medical, Inc.. Currently has a direct ownership of 0 shares of SWAV, which is worth approximately $0. The most recent transaction as insider was on Aug 18, 2021, when has been sold 45,000 shares (Common Stock) at a price of $3.42 per share, resulting in proceeds of $153,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Douglas Evan Godshall Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 18 2021	BUY Exercise of conversion of derivative security	$153,900 $3.42 p/Share	45,000 Added 19.84%	181,856 Common Stock
May 18 2021	SELL Open market or private sale	$7,110,900 $158.02 p/Share	45,000 Reduced 24.74%	136,856 Common Stock
May 18 2021	BUY Exercise of conversion of derivative security	$153,900 $3.42 p/Share	45,000 Added 19.84%	181,856 Common Stock
Apr 23 2021	SELL Payment of exercise price or tax liability	$292,781 $159.38 p/Share	1,837 Reduced 1.32%	136,856 Common Stock
Feb 18 2021	SELL Open market or private sale	$5,513,400 $122.52 p/Share	45,000 Reduced 23.27%	148,359 Common Stock
Feb 18 2021	SELL Payment of exercise price or tax liability	$1,190,755 $123.19 p/Share	9,666 Reduced 6.52%	138,693 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	$153,900 $3.42 p/Share	45,000 Added 18.88%	193,359 Common Stock
Feb 01 2021	BUY Grant, award, or other acquisition	-	50,000 Added 25.21%	148,359 Common Stock
Nov 18 2020	SELL Open market or private sale	$1,555,351 $96.42 p/Share	16,131 Reduced 14.09%	98,359 Common Stock
Nov 18 2020	BUY Exercise of conversion of derivative security	$55,168 $3.42 p/Share	16,131 Added 12.35%	114,490 Common Stock
Nov 17 2020	SELL Open market or private sale	$12,450,702 $94.22 p/Share	132,145 Reduced 57.33%	98,359 Common Stock
Nov 17 2020	BUY Exercise of conversion of derivative security	$451,936 $3.42 p/Share	132,145 Added 36.44%	230,504 Common Stock
Nov 16 2020	SELL Open market or private sale	$12,413,669 $94.24 p/Share	131,724 Reduced 57.25%	98,359 Common Stock
Nov 16 2020	BUY Exercise of conversion of derivative security	$450,496 $3.42 p/Share	131,724 Added 36.41%	230,083 Common Stock

Also insider at

EYPT

EyePoint Pharmaceuticals, Inc. Healthcare

DEG